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During. recent symptomatic toxoplasmosis, alterations in quantity and function of
mononuclear cellsin peripheral blood were observed. Flow cytofluorometric analysis and
differential leukocyte counts revealed increasedabsolute numbers of T8 + cells, Leu 7 +
(natural killer/killer) cells, and monocytes. T4+ cells and HLA-DR+ cells were not sig-
nificantly changed. T4/T8 cell ratios were reversed in symptomatic toxoplasmosis (0.7
± 0.3) and normal in chronic infection (1.7 ± 0.5). Toxoplasma antigen induced higher
numbers of T8 -+- aridTQl + cells in four T cell lines from two individuals with sympto-
matic infection than in five T cell lines from three individuals with asymptomatic infec-
tion. Eight cloned T cell lines produced y interferon in an antigen-specific fashion and
in higher amounts when they originated from an asymptomatic subject than from a symp-
tomatic subject. These results indicate that marked alterations in properties of im-
munoregulatory cells are characteristic of recent symptomatic toxoplasmosis. The tran-
sient immune dysfunction may be a major part of the observed disease and/or a feature
of successful parasitism.
Infection with the coccidian protozoan Toxoplasma
gondii causes no illness in most individuals. In about
one of five infected individuals, various degrees of
fatigue, malaise, fever, and lymph node enlargement
are recorded [1]. These subjects recover without re-
sidual signs of disease; this distinguishes them from
those with documented immune deficiency, in whom
toxoplasmosis is often severe and even fatal [2]. It
has also been noted that evidence of cellular immune
response to toxoplasma antigens is delayed in ap-
pearance in some patients, compared with the ki-
netics of response to other antigens [1, 3, 4]. In an
effort to understand better immune responses dur-
ing acute symptomatic infection, we examined total
T cell subsets and toxoplasma antigen-induced T cell
subsets during toxoplasmosis.
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Subjects and Methods
Subjects. A total of 22 individuals was studied.
T cell surface markers of peripheral blood lympho-
cytes (PBLs) were studied in 19 individuals with use
of monoclonal antibodies and a Cytofluorographs'
(Ortho Instruments, West Wood, Mass). According
to the history of infection by T. gondii, three groups
of subjects were defined. Six Iloninfected individu-
als (mean ± SD age, 29 ± 11years) were compared
with five chronically infected individuals (mean ±
SD age, 33 ± 7 years) and eight patients with recent
symptomatic toxoplasmosis (mean ± SD age, 26 ±
6 years).
The noninfected individuals were negative for IgG
antibody to Toxoplasma by the immunofluorescence
test at a serum dilution of 1:5. The chronically in-
fected individuals were positive for IgG (mean titer,
1:300),w~renegative for IgM by conventional in-
direct immunofluorescence test, and had had no c1in-
icallymanifest toxoplasmosis in the past. All the sub-
jectswith recent symptomatic toxoplasmosis had
IYl!1pll.Cldenopathy of more than one week in dura-
tiBn,andseveilof the eightalso had elevated tem-
Q~gt!}!I£~{~7=-~8CJ. and malaise. In each of these
iIlgiYH;ll!~J~,l1igllor rising titers of IgG antibodies
t01bxoplasma and a titer of IgM antibodies of ~1 :50
weredemonstrated by the immunofluorescence test.
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These subjects reported fluctuations in lymph node
size for up to six months after infection.
Toxoplasma antigen-specific T cell lines were
generated from five subjects. The two designated by
A had a history of recent symptomatic toxoplasmo-
sis. Subject Al was a 22-year-old man with lymph-
adenopathy of two weeks in duration, elevated tem-
perature, and malaise who was positive for IgM
antibody to Toxoplasma and had a titer of IgO anti-
body of 1:3,200 by the indirect immunofluorescence
test. Subject A2 was a 36-year-old woman with a his-
tory of a short period of fever, followed by malaise
and fatigue, associated with submandibular lymph-
adenopathy that progressed to generalized lymph-
adenopathy in the cervical, axillary, and inguinal
regions. The enlarged lymph nodes persisted for four
months. The titer of IgM antibody to Toxoplasma
was 1:64 and that of IgO antibody was 1:4,000. This
patient was chosen for study even 21 months after
infection because she was one of those rare individ-
uals without known underlying immunodeficiency
who develop severe toxoplasmosis. Two subjects
designated by B had no history of clinical illness,
nolgM antibody to Toxoplasma by immunofluores-
cence, and low titers of IgG antibody (1:160 and
1:320, respectively). One asymptomatic 52-year-old
subject designated C had had Hodgkin's disease nine
years ago (stage IIA). The excision biopsy specimens
of his bilateral cervical lymphomas were macroscop-
ically characteristic of tumor. Histological exami-
nation showed malignant cells of Hodgkin's disease,
Sternberg-Reed cells, and lymphocytic depletion. He
was treated with irradiation (4,400 rad; model Linac
SL 75/5; Philips, Crawley, England) and chemother-
apy (vinblastine, lomustine, prednisone, and procar-
bazine), and he has been in full remission for six
years. The Sabin-Feldman dye test was first positive
nine years ago (titer, 1:4,000), but CF antibodies were
absent. Six years later the titer of IgG antibody was
1:6,000, and it was elevated at a titer of 1:25,600 at
the time of the present study.
Cytofluorometry analysis ofPBL subsets. PBLs
from all patients were isolated by centrifugation with
a gradient of Ficoll-Paque" (Pharmacia, Uppsala,
Sweden). Erythrocyte-rosette enrichment was not
performed so that studies of non-T lymphocytes
(natural killer/killer [NK/K] cells) [5] could be done
as well. The yield of T cells was 60070-76070, which
is comparable to that of the buffy coat technique
[6]. After washing, 1.5 x 106 PBLs were maintained
for 45 min in ice with monoclonal antibodies Leu
Sklenar et at.
3a (Becton-Dickinson, Mountain View, Calif) or
OKT 4 (Ortho Diagnostic Systems, Raritan, NJ), an-
tibody to T4 cells and helper/inducer T cell marker,
respectively; Leu 2b (Becton-Dickinson) or OKT 8
(Ortho), antibody to T8 cells and cytotoxic/suppres-
sor cell marker, respectively; and antibody to TQI
(Coulter Immunology, Hialeah, Fla), a marker of
T cell suppressor subsets [7]. After washing with an
excess of HEPES-buffered modified Eagle's medi-
um, the cells were incubated with FITC-conjugated
goat antibody to mouse immunoglobulin (Becton-
Dickinson). After further washing the samples were
resuspended in PBS without Mg'" and Ca" and ana-
lyzed in a Cytofluorograph" (model 50 HH; Ortho
Instruments, West Wood, Mass) combined with a
computer (model 2150; Ortho Instruments). By ex-
citation of the cells with argon laser light at a wave-
length of 488 nm (500 mW), 90° scatter, forward
narrow-angle scatter, and green fluorescence could
be measured simultaneously. The numbers of lym-
phocytes were counted in the lymphocyte cluster of
the scatter cytogram (figure 1), and the numbers of
immunoflourescent cells were recorded. Gating was
kept identical in the samples from each subject. Dead
cells and debris were eliminated from the scatter of
fluorescence analysis by electronic gating out of cells
with low scatter signals. Viability of cells was >90070
by exclusion of ethidium bromide. Background
fluorescence obtained with the FITC conjugate was
subtracted. The percentage fluorescence acquired
from 30,000 cells and the total lymphocyte count
from the whole blood were used to calculate the ab-
solute number of different cell types.
In addition, in four individuals (two acute symp-
tomatic subjects and two controls) the cells of the
lymphocyte cluster were characterized with use of
staining with OKT 3 (for pan T cell), OKT 4, OKT
8 (all from Ortho), and antibody to HLA-DR
(Becton-Dickinson; for monocytes and B cells). The
contents of the Leu 7/HNK I-positve cells and the
cells showing simultaneous green (T8 positive) and
red (Leu 7 positive) fluorescence in the lymphocyte
cluster of these four individuals were determined
with use of dual laser flow cytofluorometry. In eight
individuals (five acute symptomatic subjects and
three controls), analysis with Leu 7 (NK/K cell
marker) was performed. Texas Red-avidin (E.Y.
Labs, San Mateo, Calif) was used to develop biotin-
conjugated antibody to HLA-DR or antibody to Leu
7 on the lymphocyte surface. The cells werethen ana-
lyzed for the presence of red fluorescence. In three
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Figure 1. Laser light scatter cytogram of 30,000 periph-
eral blood mononuclear cells: (A) cells originating from
a noninfected control and (B) cells from a subject with
acute symptomatic toxoplasmosis. Forward narrow-angle
scatter is shown on the ordinate, with 90 0 scatter on the
abscissa. Analysis with monoclonal antibodies of regions
1 and 2 showed that they consi sted predominantly of lym-
phocytes and monocytes.
the buffy coat of a freshly donated unit of blood
(500 ml with acid citrate-dextrose anticoagulant)
were stimulated with 50 /-Ig of phytohemagglutinin
(PHA; GIBCO, Grand Island, NY)/ml and 2 x 105
24-hr-old allogeneic PHA-induced PBL blasts/ml in
Dulbecco's and alpha medium (l :1;GIBCO) and 2010
human type AB serum. After 36 hr the supernatants
were harvested, sterile filtered, and tested on PHA-
induced blasts for promotion of T cell growth and
DNA synthesis.
Generation of toxoplasma-specific T cell lines.
Soluble antigen was prepared from the RH strain of
T. gondii as previously described [10]. All five sub-
jects studied were pretested in an eight-day lympho-
cyte transformation assay with the antigen to deter-
mine the optimal dose for maximal proliferation. In
general, this dose was lO-l00/-ig/mI. PBLs, 2 x 106/2
ml, from each subject were incubated for eight days
with two doses of antigen (10 and 100 /-Ig/ml) in 24-
well culture plates (Costar, Cambridge, Mass). Af-
ter eight days the cells were harvested, pooled, and
resuspended in fresh conditioned medium. The cells
were expanded in culture plates (Costar) by renewal
of the medium every three days. After two weeks in
culture the cells were tested for toxoplasma anti-
gen-specific proliferation. Flat-bottom 96-well plates
(Micro Test II®; Falcon, Oxnard, Calif) were in-
cubated with 1.5 x lOSirradiated (3,000 rad) autol-
ogous PBLs in medium with 10010 type AB serum
for I hr. The nonadherent cells were harvested, the
wells were washed with PBS, and the recovered cells
were counted. By this method the number of adher-
ent cells (ACs) was calculated and found to be
20%-30010 of the original number of plated cells.
ACs in the wells served as antigen-presenting cells.
The T cell lines (I05 per well in duplicate wells) were
cultured for 72 hr in the presence of ACs plus 100
/-Ig of toxoplasma antigen/ml, 10 /-Ig of tetanus tox-
oid (Institut Serotherapique et Vaccinal Suisse Berne,
Bern, Switzerland)/ml, or ACs alone. For the last
8 hr of culture the cells were pulsed with 0.25 /-ICi
of [125I]deoxyuridine per well and harvested
(Titertek'" cell harvester; Flow Laboratories, Irvine,
Ayrshire, Scotland). The number of cpm was deter-
mined in a y counter (Packard Instrument Co.,
Downers Grove, Ill). Only when toxoplasma anti-
gen-specific proliferation was documented was the
distribution of the T cell markers T4, T8, and TQl
of a line studied. The indirect immunoflouroescence
method was used. T cells (106 ) were reacted with the
monoclonal antibodies for 45 min in ice, washed•
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patients the cells of the monocyte cluster (figure lB,
region 2) were analyzed with use of monoclonal an-
tibody Leu M3 (monocyte marker) and FITC-con-
jugated goat antibody to mouse immunoglobulin
(Becton-Dickinson).
Toxoplasma-specific T cell lines. Media. Dulbec-
co's modified Eagle's medium with addition of an-
tibiotics and amino acids was used [8]. Pooled, heat-
inactivated human type AB serum was added in a
10% concentration. T cell lines were cultured and
expanded with use of medium conditioned with WOJo
crude human interleukin-2 prepared as described
previously [9J. In brief, leukocytes (4 x 106/ml) from
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and reacted with FITC-conjugated goat antibody to
mouse immunoglobulin. After washing, the percent-
age of fluorescent cells was determined by counting
200 cells with the immunoflouorescence microscope.
Limiting-dilution cultures. Toxoplasma-specific
T cell sublines were obtained from one of the pa-
tients with recent toxoplasmosis (A2) and one of the
individuals with chronic infection (B2) according to
previously described techniques [8]. Microtiter plates
with irradiated autologous AC feeder layers were
used. Toxoplasma antigen (50 JAg/ml) and medium
conditioned with 5070 interleukin-2 were used in
limiting-dilution cultures of 100, 10, and 1 cells per
well. Only the dilution containing 10 cells per well
showed a favorable cloning efficiency (13070 of wells
positive) and allowed selection of sublines of both
T4- and T8-enriched cells. The proliferative re-
sponses to toxoplasma antigen of the T4 and T8 sub-
lines were studied with use of the same protocol de-
scribed above.
Production of y interferon (IFN-y) by Toxoplas-
ma-specific T cell lines and sublines. Irradiated
ACs, 1 x lOS, and 5 x 105 T cells were incubated
with 50 JAI of toxoplasma antigen/ml, purified pro-
tein derivative (Institut Serotherapique et Vaccinal
Suisse Berne), or PHA. After 72 hr the supernatants
were harvested, filtered, and frozen. The superna-
tants were tested for IFN in a CPE inhibition assay
[11] with use of WISH cells (3 x 104 per well). In
brief, WISH cells were incubated for 24 hr with su-
pernatants titrated in threefold dilutions and then
infected with Mengo virus (800 pfu). The antiviral
IFN-y activity was measured as the dilution of the
supernatant that prevented 50070 of the CPE. The
supernatants were compared with an IFN-y standard
obtained from Dr. S. Grossberg (Department of
Microbiology, Medical College of Wisconsin, Mil-
waukee), and the concentration was recorded in
V/ml. The IFN-y in the supernatants was demon-
strated to be acid labile by treatment at pH 2.5.
Statistical methods. The t test statistics were per-
formed, and the correlation coefficient was calcu-
lated.
Results
Analysis of peripheral blood mononuclear cells
according to size. Figure IA is the cytogram of cells
from a control, noninfected individual. Figure IB,
a cytograrn of cells from a subject with acute symp-
tomatic toxoplasmosis, shows two cell populations
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markedly different from those of the control in-
dividual with regard to laser light scatter character-
istics. The region designated by 1 has been identi-
fied previously as a lymphocyte cluster, and region
2 has been identified as a monocyte cluster [6]. Six
of eight of our symptomatic subjects and only one
of six controls showed increased numbers of cells
in region 2. To evaluate cells in this cluster, the dis-
tribution of cells with the markers Leu M3, T8, and
T4 in both regions was studied in three subjects.
Their ages were 28, 20, and 33 years, and they had
been infected two, five, and six months ago. In these
individuals 16.1070 ± 2.3070 cytofluorometrically
screened cells were found in region 2, comprising
67070-75070 Leu M3-positive cells (monocytes),
16070-30070 T8-positive cells, and 0070-7070 T4-positive
cells, depending on fluorescence intensity gating.
Region 1 (the lymphocyte cluster) was studied in
two subjects with symptomatic toxoplasmosis (23
and 31 years of age, infected two months ago) and
two noninfected controls (23 years of age) with use
ofOKT 3,4, and 8 and antibody to HLA-DR (table
1). The number of total T cells (T3 positive) in the
lymphocyte cluster ranged from 60070 to 76070. In pa-
tients with symptomatic toxoplasmosis, the percent-
age of T4-positive (helper marker) cells was slightly
lower, and the percentage of T8-positive (cytotoxic
suppressor marker) cells was slightly higher in the
lymphocytes clustered in region 1, similar to the al-
terations seen in region 2, and the absolute numbers
of T8-positive cells were greater (see below). The
number of HLA-DR-positive (B cells and mono-
cytes) cells was not different in patients and controls
in region 1. The numbers of cells showing the Leu
7/HNK 1 (NK/K) marker as well as the dual T8 and
Leu 7 marker were increased in the patients. This
observation was confirmed by additional analysis of
three patients (see below).
T8-, TQl-, and Leu 7-positive cells in peripheral
blood ofpatients. Table 2 shows characteristics of
the individuals studied and summarizes the results
of peripheral T cell subsets contained in the lympho-
cyte cluster analyzed by three monoclonal antibod-
ies with use of flow cytofluorometry. The absolute
numbers of T8-positive cells/mm" were significantly
higher (P< .001) in individuals with recent toxoplas-
mosis (one to six months ago) than in chronically
infected individuals and in noninfected controls.
The T4/T8 cell ratio was significantly lower in sub-
jects with recent toxoplasmosis compared with
chronically infected and noninfected individuals (P
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Table 1. Analysis of the lymphocyte cluster.
-----
---- ---
Percentage of fluorescent cells
Individuals studied T3+ T4+ T8+ HLA-DR+ Leu 7+ Leu 7 + /T8 +
-- -------
--- --
Symptomatic toxoplasmosis
1 (8 weeks ago) 68.8 25.1 41.4 5.2 26.3 18.8
2 (10 weeks ago) 64.5 18.4 32.0 3.5 14.8 11.1
No infection
1 60.4 32.9 31.5 4.9 10.7 9.0
2 76.0 63.4 16.5 7.1 7.6 5.4
--_.--. __ ._-
--_..--.
. --,--- ----.-
NOTE. The cells were analyzed with use of antibodies to lymphocyte surface antigens: T3 (pan T cell marker), T4 (helper cell
marker), T8 (cytotoxic/suppressor cell marker), HLA-DR (B cells and monocytes), and Leu 7/HNK 1 (NK/K cell marker). Leu
7/T8-positive cells were detected by dual laser cytofluorometry for simultaneous green and red fluorescence.
< .001 and P < .01, respectively). This difference was
not due to decreased numbers of T4-positive
(helper/inducer) cells, which did not differ signifi-
cantly among all three groups of individuals. In ad-
dition, the number of cells positive for TQl marker
(the marker of certain suppressor cell subsets) [7,
12]did not vary in the three groups. Absolute mean
± SD numbers of TQl-positive cells/rum" were 643
± 331 in recent toxoplasmosis (n = 3), 576 ± 399
in chronic infection (n = 5), and 560 ± 231 in con-
trols (n = 3).
The number of Leu 7-positive (NK/K) cells in five
patients with acute toxoplasmosis (mean ± SD age,
27 ± 5 years) was significantly increased compared
with three noninfected controls (mean ± SD age,
32 ± 15; table 2). This increase was not due to the
age of the subjects noted in the normal population
[5] because ages in the two groups were comparable.
Peripheral blood monocytes in acute toxoplasmo-
sis. The light scatter cytogram suggested increased
numbers of monocytes in persons with acute symp-
tomatic toxoplasmosis. This proposal was confirmed
by analysis of the differential blood counts from all
patients studied. Acutely infected patients had 631
± 203 monocytes/rnm" (9.4070 ± 2.9070), those
chronically infected had cell counts of 516 ± 248
(7.2070 ± 2.8070), and controls had cell counts of 402
± 177 (6.2070 ± 1.9070), results indicating significant
monocytosis (P < .05) in acutely infected patients.
Time course of changes in monocytes and T8-
positive cells during acute infection. Monocyte lev-
els were increased during the first two months after
infection but reached normal levels by five to six
months (figure 2). There was a significant inverse
correlation between the absolute number of mono-
cytes and the time after infection (y = - 91.6x +
906, r = -.89, P< .01). In contrast, T8-positive lym-
phocyte numbers were increased from the earliest
Table 2. Characterization of subjects and their PBL subpopulations.
Acute symptomatic 26 ± 6 1:4,200
toxoplasmosis (n = 8)
Chronic asymptomatic 33 ± 7 1:300
infection (n = 5)
Noninfected 29 ± 11 0
controls (n = 6)
Individuals studied
Age
(years)
Mean serum titer
of IgG antibody
Absolute cell number/rum"
T4+ T8+ Leu 7+ T4/T8
--
--'._---'- --" -_ ..__._--
628 ± 242 988 ± 190 693 ± 329 0.7 ± 0.3
(23.4 ± 10) (37 ± 9) (28.4 ± 11)*
680 ± 253 437 ± 241 NT 1.7 ± 0.5
(30.4 ± 14) (19 ± 8)
894 ± 445 517 ± 167 212 ± 15 1.8 ± 1.0
(42 ± 11.2) (25.3 ± 7) (11 ± 3)t
_.
._._-
---._-
NOTE. Data are mean ± 3D values (percentages as indicated). Subjects with acute symptomatic toxoplasmosis (AS) had been
infected three months (range, one to six months) previously, whereas those with chronic asymptomatic infection (CA) had been
infected many years previously. P values for comparisons were obtained with use of t test statistics: for T4 + , not significant for
AS vs. CA and AS vs. noninfected individuals (N); for T8 +, P < .001 for AS vs. CA and AS vs. N; for Leu 7 +, P < .05 for
AS vs. N; and for T4/T8, P < .001 for AS vs. CA and P < .01 for AS vs. N. Not tested = NT.
* n = 5.
t n = 3.
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1 2 3 4 5 6
MONTH AFTER TOXO INFECTION
Figure 2. Alterations in numbers of the circulating
monocytes and T8-positive lymphocytes in eight subjects
with acute symptomatic toxoplasmosis in relation to time
(months) after infection. Absolute numbers of cells/rum-
of blood are shown. The mean ± SD (bars) values from
six noninfected individuals are also shown (0). Chroni-
cally infected patients showed the same values for counts
of monocytes (516 ± 248 cells/mm") and T8-positive cells
(437 ± 241 cells/rnm'). Regression analysis (by the least
squares method) is depicted by the dotted lines. A sig-
nificant inverse correlation was found for monocytes (r
= - .89, P < .01) but not for T8-positive cells.
period after infection up to six months after infec-
tion and did not show a significant decline during
the study period.
T8- and TQ1-positive subsets in Toxoplasma-
specific T eel/lines. T cell lines induced from PBLs
with use of soluble toxoplasma antigen that prolifer-
ated specifically on restimulation with antigen and
syngeneic ACs were studied with use of monoclonal
antibodies and indirect immunofluorescence. T cell
lines obtained from two recently infected and clini-
cally ill individuals (AI, with illness two months ago,
and A2, with illness 21 months ago) contained higher
numbers of T8-positive (suppressor/cytotoxic) and
TQI-positive (suppressor subsets) cells than lines
from chronically infected individuals BI and B2, with
no history of lymphadenopathy and fever (table 3).
Subject AI, studied for the first time two months
after onset of symptoms, had a T4/T8 cell ratio in
peripheral blood of 0.5, and the T cell lines showed
increased proliferation of antigen-specific T8-posi-
tive cells (62%). At five months after infection, the
T4/T8 cell ratio was still low (0.6). Subject A2, stud-
ied 21 months after infection with Toxoplasma,
which caused an illness of four months in duration,
had a normal ratio of peripheral T4/T8 cells (2.2),
but T cell lines still showed predominantly Toxoplas-
ma-specific T8-positive cells (700,70) when induced
in vitro by antigen. This observation was in contrast
to the behavior of T cell lines obtained from the
chronically infected individuals BI and B2, who had
normal peripheral T cell subset ratios (l.l and 2.0)
and whose lines showed lower numbers of T8-
positive cells (300,70-400,70).
In addition, one individual with Hodgkin's dis-
ease was studied (subject C). This subject demon-
strated very low numbers of Toxoplasma-induced T8-
positive cells in T cell lines and very high serum titers
of IgG antibody to Toxoplasma. This pattern of re-
sponse is unusual and distinct from that of subjects
with recent symptomatic toxoplasmosis, who had no
other known underlying disease, and that of chron-
ically infected but otherwise healthy individuals.
Proliferation and IFN-y production by Toxoplas-
ma-specific T eel/lines. The proliferative responses
of the T cell lines obtained from subjects with re-
cent toxoplasmosis and latently infected individu-
als were antigen specific. Only toxoplasma antigen
and ACs caused proliferation, whereas incubation
of the lines with ACs alone (table 4) or with ACs
and tetanus toxoid (data not shown) yielded no stim-
ulation. Unseparated PBLs from three of five indi-
viduals showed strong proliferation in response to
tetanus toxoid (data not shown).
With use of limiting dilution, Toxoplasma-specific
sublines highly enriched for one marker (either T4
or T8) were obtained (table 4). In one subject with
recent toxoplasmosis (A2), SLI, depleted of T8-
positive cells, showed significantly higher prolifera-
tion than the parent line, which contained 73070 T8-
positive cells, and SL2, which had 99070 T8-positive
cells. Similarly, in one chronically infected individual
(B2), T8-depleted SLI (00,70 T8-positive cells) prolifer-
ated more than the parent line, with 30070 T'S-positive
cells, and SL2, with only 70,70 T4-positive cells.
Two lines obtained from subject C, which con-
tained very low numbers of T8 cells (9070 and 3%)l
showed high 51 values (38- and 33-fold). These data
suggest that an inverse correlation exists between the
magnitude of proliferation of toxoplasma anti-
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Table 3. P~~_~ent~~es of T8- and TQ I-positive __~ells in Toxoplasma-specific T cell lines.
Antigen (j.Lg/ml)
Subject used for induction T8 (070) TQI (070)
---------
--- ----" ..__._--
Symptomatic toxoplasmosis
A I (2 months ago) 100 43 63
10 62 54
A2 (21 months ago) 100 73 NT
10 68 NT
Asymptomatic infection
B1 (years ago) 100 40 32
10 31 38
B2 (years ago) 100 30 NT
C (9 years ago) 50 9 NT
5 3 NT
-----._---_._--_._-
T4/T8
(blood)*
0.5
2.2
2.0
1.1
NT
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IgG titer
(serum)t
1:3,200
1:160
1:160
1:320
1:25,600
NOTE. T cell lines induced with toxoplasma antigen (5-100 lig/ml) and demonstrated to proliferate specifically with the antigen
were tested with monoclonal antibodies (to T8, a cytotoxic/suppressor cell marker, and to TQl, a marker of suppressor cell subsets)
with use of indirect immunofluorescence.
* T4/T8 (helper/suppressor) cell ratios were measured in peripheral blood at the beginning of the T cell line induction.
t The titer of IgG antibody to Toxoplasma was measured with use of indirect immunofluorescence.
gen-specific T cell lines and the number of T8-
positive cells that they contain.
Table 4 shows the production of IFN-y by T cell
sublines enriched for one cell type. The two sublines
obtained from subject A2, with a history of
prolonged disease syndrome that started 21 months
ago, produced low levels of IFN-y (10 and 80 U/ml)
after antigen stimulation. None of the six T cell sub-
lines obtained from an asymptomatic individual
(subject B2) showed such low levels. Stimulation with
the mitogen PHA of lines that produced low levels
of IFN-y in response to antigen induced high levels
of IFN-y. T4 cell sublines (A2 SLI and B2 SLl), one
non-T4 subline (B2 SL2), and all uncharacterized
Table 4. Proliferation and IFN-y production by Toxoplasma-specific T cell lines and sublines.
Proliferation IFN-y
Subject, line or (cpm) with T8-positive cells (Vlml) after
subline (antigen dose)* ACs plus antigen ACs alone Percentage SI Antigen PHA
----
A2
P (l00) 16,663 ± 1,534 3,940 ± 492 73 10 20 NT
SLI (50) 71,335 ± 5,515 83 ± 32 1 859 80 500
SL2 (50) 4,631 ± 762 504 ± 106 99 9 10 700
H2
P (l00) 7,811 ± 2,107 932 ± 315 30 8 NT NT
SLl (50) 10,614 ± 17 173 ± 49 0 61 700 NT
SL2 (50) 5,390 ± 565 1,219 ± 98 t 4 1,400 NT
SL3 (50) 15,886 ± 4,815 1,187 ± 146 NT 13 240 NT
SL4 (50) 4,399 ± 157 77 ± 25 NT 57 500 NT
SL5 (50) 3,220 ± 591 82 ± 7 NT 34 150 NT
SL6 (50) 2,480 ± 319 330 ± 67 NT 8 500 NT
C
PI (50) 12,162 ± 1,499 319 ± 235 9 38 150 NT
P2 (5) 16,425 ± 440 494 ± 63 3 33 1,400 NT
NOTE. Subject A2 was a patient with symptomatic toxoplasmosis, subject B2 was an asymptomatic patient with chronic tox-
oplasma infection, and subject C was an asymptomatic patient with Hodgkin's disease in remission. Data are mean ± SD values
as indicated. P = parent line; SL = subline, enriched by limiting dilution for one cell type; and SI = stimulation index.
* Toxoplasma antigen in lig/ml used to induce the line.
t SL2 contained 7070 T4-positive cells; T8-positive cells were not tested.
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sublines from an asymptomatic patient (B2 SL3-6)
produced IFN-y after stimulation with toxoplasma
antigen. Stimulation of the sublines with purified
protein derivative did not cause production of IFN-
y (data not shown). These antigen-specific sublines
may reflect true production of IFN-y because they
do not contain significant numbers of undefined cells
that could consume lymphokine [13]. Nonenriched
T cell lines (i.e., mixed T cell lines) from all individ-
uals studied that were induced with a high dose of
toxoplasma antigen (50-100 ug/ml) demonstrated
low production of IFN-y, whereas lines induced with
lower antigen doses (5-10 ug/ml) produced higher
amounts. This variability is very likely a result of
conflicting influences on production and consump-
tion of IFN-y by undefined cells. The line from sub-
ject C that contained only 3070 T8-positive cells pro-
duced the highest amounts of IFN-y, 1,400 V/ml
(table 4), of all nonenriched lines studied.
Discussion
Observations reported here indicate that marked al-
terations in antigen-specific T cell populations and
in monocyte numbers occur during the first months
after symptomatic infection with Toxoplasma. The
alterations include high numbers of total cells posi-
tive for T8, Leu 7, and both T8 and Leu 7, decreased
T4/T8 cell ratios, high numbers of monocytes in pe-
ripheral blood, and a high percentage of T8- and
TQl-positive cells in toxoplasma antigen-induced T
cell lines. The abnormalities in total peripheral blood
T cell subsets were seen as late as six months, but
not 20 months, after symptomatic illness, whereas
high numbers of T8-positive cells in antigen-inducer
T cell lines were seen as late as 21 months after in-
fection in one individual. In contrast, chronically in-
fected subjects had normal numbers of T8-positive
cells, normal T4/T8 cell ratios, and fewer T8-positive
cells in response to toxoplasma antigen in T cell lines.
Two reports [14, 15] have shown similar changes
in peripheral blood T cell subsets during toxoplas-
mosis. De Wae1e et al. [14] studied one recently in-
fected patient with toxoplasmosis, Luft et al. [15]
studied six patients, and we now add eight more pa-
tients, all of whom showed an increase in number
of T8-positive cells in peripheral blood. In the pres-
ent study asymptomatic patients infected chronically
with Toxoplasma were also evaluated, and they
showed peripheral blood T cell populations similar
to those of control subjects. Luft et al. [15] studied
Sklenar et at.
four patients who were asymptomatic although re-
cently infected. These individuals also showed nor-
mal numbers of T8-positive cells, which distin-
guished them from the symptomatic patients studied
by Luft et al. [15] and by us. This single observation
raises the possibility that an increase in number of
T8-positive cells is a correlate of the disease state and
not simply indicative of recent infection. Two of our
patients provide some support for a relation between
symptomatic infection and PBL abnormalities.
The illness, lymphatic toxoplasmosis, may be con-
sidered an immunologic disease initiated in some in-
dividuals by the infectious process. T. gondii is simi-
lar to the two viruses known to cause mononucleosis,
Epstein-Barr virus and cytomegalovirus, in that both
lymphadenopathy and increased numbers of T8-
positive cells in the peripheral blood have been
recorded [16, 17]. Similar to the cases reported here,
the abnormalities in lymphocyte subsets caused by
cytomegalovirus have persisted up to 10months af-
ter infection [17]. Prolonged abnormalities in lym-
phocyte subsets have recently been observed during
acute infections with retrovirus [18]. It has not been
possible to elucidate the reasons for the changes in
T cell subsets during these infections.
This is the first study of the populations of cells
seen in response to toxoplasma antigen in individu-
als with recent, symptomatic, or chronic asymptom-
atic infections. The increased antigen-specific selec-
tion of T8-positive cells suggests that the altered
ratios of total T cells are due to antigen-specific re-
sponse patterns. Large numbers of T8-positive cells
were generated in subjects with recent toxoplasmo-
sis, unrelated to the antigen dose used. In vitro
proliferation was toxoplasma antigen specific, and
it tended to be highest in cell cultures with a pre-
dominance of T4-positive cells. A correlation of pre-
dominance of T4-positive cells after induction with
toxoplasma antigen, enhanced in vitro proliferation
in response to antigen, and high serum titers of an-
tibody was demonstrated in one individual (subject
C) with a history of Hodgkin's disease and infec-
tion with Toxoplasma. The data, based on a few sub-
jects, suggest the possibility that the T8-positive cells
observed to be increased during toxoplasmosis may
modulate the proliferation of T4-positive cells to
toxoplasma antigen in vitro and the magnitude of
the humoral response to Toxoplasma in vivo. Al-
though antigen-specific T8-positive suppressor cells
have been described [19],the mechanisms of the sup-
pression are unknown [20-23]. The finding of in-
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creased numbers of TQl-positive cells (a marker de-
scribed on suppressor T cell subsets) [7, 12]in T cell
lines induced by toxoplasma antigen from a symp-
tomatic subject supports the view that T cells with
a negative immunoregulatory role are induced by this
antigen.
Antigen-induced T8-positive cells may also occur
in individuals infected with Epstein-Barr virus,
cytomegalovirus, and retrovirus, although studies of
these viral infections similar to those described here
have not been done. Antigen-specific immunity to
herpes simplex virus type 2 has been studied in indi-
viduals in various phases of infection [24].
The mechanism responsible for selection of T8-
positive cells is unknown. It does not appear to be
dependent on antigen dose because both 10and 100
ug/ml induced large numbers of T8-positive cells in
subjects with recent toxoplasmosis. Antigen fraction-
ation must be done to determine whether some toxo-
plasma antigens are more likely than others to in-
duce this response in vitro. Our data suggest that even
after total T cell ratios are normal, antigen-specific
induction still favors T8- over T4-positive cells. Long
after infection, individuals appear to have the net-
work for protective immunity with rapidly prolifer-
ating, functioning T4-positive cells.
Enhancement of NK cell activity has been de-
scribed in the mouse model [25] and in human lym-
phocyte cultures [26] in response to toxoplasma
antigens. In humans with acute symptomatic toxo-
plasmosis, we found increased numbers of circulat-
ing cells carrying the marker of NK and K cells (Leu
7/HNK 1). Such cells could be associated with kill-
ing of parasite-infected cells via antibody-dependent
cell-mediated cytotoxicity [27], or they may contrib-
ute additional down regulation of the immune re-
sponse because Leu 7-positive suppressor cells have
been described [28]. In addition, two subjects with
acute toxoplasmosis had increased numbers of cells
carrying a dual marker of cytotoxic cells (T8) and
of NK cells (Leu 7). Leu 7-positive cells carrying
simultaneously the T8 cell marker have been de-
scribed as immature bone marrow NK cells [29].
The Toxoplasma-infected subjects in this study
had, in addition to the changes in lymphocyte sub-
sets, increased numbers of monocytes in peripheral
blood up to the second month after infection. This
finding is of interest because toxoplasmosis in ani-
mal models has been found to be associated with
increased numbers of monocytes and macrophages
at various sites [1, 30, 31] (T.e.J., S.A., and P.E., un-
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published observation) and in degree of activation
[30]. Because T cell regulation of the myelopoiesis
by production of monocyte colony-stimulating fac-
tors after specific antigenic stimulation of cloned T
cells has been recently demonstrated [32], it is pos-
sible that the increased numbers of monocytes in our
symptomatic subjects were due to the described ex-
pansion of T cell subsets.
We found that cloned T cells of both the T4 and
the T8 phenotypes from one symptomatic individual
produced less IFN-y after stimulation with toxo-
plasma antigen compared with T cells from an asymp-
tomatic individual. This finding may represent
(besides increased numbers of T8-positive cells in re-
sponse to toxoplasma antigen in vitro) another
marker that identifies individuals prone to manifest
disease. This suggestion is supported by a study that
showed that in the course of acute symptomatic toxo-
plasmosis, one patient's cells' ability to inhibit Toxo-
plasma was initially impaired [4].
Further studies are needed to determine whether
these T8-positive cells are functioning as specific sup-
pressor cells of cell-mediated processes such as T cell
proliferation, as recently suggested by Luft et al. [33],
monocyte colony stimulation [32], or specific anti-
body suppression [19], or whether these cells are ex-
panded cytotoxic cells competing for lymphokines.
All the changes shown are indicative of immuno-
logic imbalance during recent symptomatic toxoplas-
mosis. The infectious agents studied so far that cause
an imbalance of immunoregulatory lymphocyte sub-
sets (Epstein-Barr virus, cytomegalovirus, herpes
simplex virus, retroviruses, and T. gondiit have one
feature in common, namely, they cause a latent, usu-
ally life-long infection. These infectious agents ap-
pear to be capable of inducing an antigen-specific
imbalance of the immunoregulatory network lead-
ing to a postinfection immune dysfunction syndrome
of varying duration. In toxoplasmosis this syndrome
is characterized by signs and symptoms (including
lymphadenopathy, fever, and malaise) and by in-
creased numbers of circulating T8-positive/Leu
7-positive cells and monocytes and by impaired
production of lymphokines (IFN-y) by antigen-
specific T cells. The factors that contribute to emer-
gence of this syndrome in one of five Toxoplasma-
infected individuals remain undefined.
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